{"status": "Succeeded", "recognitionResults": [{"page": 1, "clockwiseOrientation": 359.94, "width": 1700, "height": 2236, "unit": "pixel", "lines": [{"boundingBox": [183, 315, 977, 316, 976, 343, 182, 342], "text": "Ms. Wakamatsu, Assistant manager, Dept. Strategic Development, et al.", "words": [{"boundingBox": [183, 318, 224, 318, 226, 341, 186, 340], "text": "Ms."}, {"boundingBox": [228, 318, 369, 319, 372, 342, 231, 341], "text": "Wakamatsu,"}, {"boundingBox": [374, 319, 475, 319, 477, 343, 376, 342], "text": "Assistant"}, {"boundingBox": [480, 319, 587, 319, 589, 343, 482, 343], "text": "manager,"}, {"boundingBox": [592, 319, 654, 319, 656, 343, 594, 343], "text": "Dept."}, {"boundingBox": [659, 319, 757, 318, 759, 343, 660, 343], "text": "Strategic"}, {"boundingBox": [762, 318, 918, 317, 919, 343, 763, 343], "text": "Development,"}, {"boundingBox": [923, 317, 945, 316, 946, 343, 923, 343], "text": "et"}, {"boundingBox": [950, 316, 976, 316, 976, 343, 951, 343], "text": "al."}]}, {"boundingBox": [154, 373, 952, 374, 951, 405, 153, 404], "text": "Attachment: NDA schedule for each project approved on the 5th GDC", "words": [{"boundingBox": [155, 375, 292, 376, 292, 403, 154, 401], "text": "Attachment:"}, {"boundingBox": [297, 376, 351, 376, 351, 404, 297, 404], "text": "NDA"}, {"boundingBox": [360, 376, 464, 377, 463, 405, 359, 404], "text": "schedule"}, {"boundingBox": [469, 377, 502, 377, 502, 406, 468, 405], "text": "for"}, {"boundingBox": [507, 377, 564, 377, 564, 406, 507, 406], "text": "each"}, {"boundingBox": [569, 377, 650, 376, 650, 406, 569, 406], "text": "project"}, {"boundingBox": [655, 376, 766, 376, 766, 405, 655, 406], "text": "approved"}, {"boundingBox": [771, 376, 799, 375, 799, 405, 771, 405], "text": "on"}, {"boundingBox": [804, 375, 843, 375, 843, 404, 804, 405], "text": "the"}, {"boundingBox": [850, 375, 887, 375, 886, 404, 849, 404], "text": "5th"}, {"boundingBox": [893, 374, 949, 374, 949, 403, 893, 404], "text": "GDC"}]}, {"boundingBox": [152, 467, 424, 470, 423, 501, 151, 498], "text": "1. Openings Remarks", "words": [{"boundingBox": [155, 470, 178, 470, 180, 497, 157, 496], "text": "1."}, {"boundingBox": [183, 470, 304, 470, 305, 500, 185, 497], "text": "Openings"}, {"boundingBox": [309, 470, 421, 470, 422, 500, 311, 500], "text": "Remarks"}]}, {"boundingBox": [153, 537, 1161, 536, 1161, 567, 154, 569], "text": "Dr. Kitazawa made opening remarks. He mentioned that TAKEDA has been driving for", "words": [{"boundingBox": [154, 539, 190, 539, 190, 568, 154, 568], "text": "Dr."}, {"boundingBox": [195, 539, 303, 539, 303, 568, 196, 568], "text": "Kitazawa"}, {"boundingBox": [309, 539, 377, 539, 377, 568, 309, 568], "text": "made"}, {"boundingBox": [382, 539, 477, 539, 476, 568, 382, 568], "text": "opening"}, {"boundingBox": [482, 539, 586, 539, 586, 568, 482, 568], "text": "remarks."}, {"boundingBox": [592, 539, 628, 539, 627, 568, 591, 568], "text": "He"}, {"boundingBox": [633, 539, 756, 538, 755, 568, 633, 568], "text": "mentioned"}, {"boundingBox": [762, 538, 811, 538, 810, 568, 761, 568], "text": "that"}, {"boundingBox": [816, 538, 920, 538, 919, 568, 816, 568], "text": "TAKEDA"}, {"boundingBox": [926, 538, 969, 537, 968, 568, 925, 568], "text": "has"}, {"boundingBox": [975, 537, 1037, 537, 1036, 568, 974, 568], "text": "been"}, {"boundingBox": [1047, 537, 1124, 537, 1123, 568, 1046, 568], "text": "driving"}, {"boundingBox": [1130, 536, 1162, 536, 1161, 568, 1129, 568], "text": "for"}]}, {"boundingBox": [155, 572, 1161, 571, 1162, 602, 155, 603], "text": "to be a global pharmaceutical company in this decade, concentrating all resource into", "words": [{"boundingBox": [155, 572, 177, 572, 178, 601, 156, 601], "text": "to"}, {"boundingBox": [183, 572, 217, 573, 218, 602, 184, 601], "text": "be"}, {"boundingBox": [223, 573, 242, 573, 242, 602, 223, 602], "text": "a"}, {"boundingBox": [247, 573, 319, 573, 319, 602, 248, 602], "text": "global"}, {"boundingBox": [325, 573, 504, 574, 504, 603, 325, 602], "text": "pharmaceutical"}, {"boundingBox": [509, 574, 615, 574, 615, 603, 510, 603], "text": "company"}, {"boundingBox": [621, 574, 647, 574, 647, 603, 621, 603], "text": "in"}, {"boundingBox": [653, 574, 700, 574, 700, 603, 653, 603], "text": "this"}, {"boundingBox": [705, 574, 798, 574, 798, 603, 706, 603], "text": "decade,"}, {"boundingBox": [803, 574, 964, 573, 964, 602, 804, 603], "text": "concentrating"}, {"boundingBox": [971, 573, 1000, 573, 999, 602, 971, 602], "text": "all"}, {"boundingBox": [1005, 573, 1109, 573, 1109, 601, 1005, 602], "text": "resource"}, {"boundingBox": [1115, 573, 1162, 572, 1161, 600, 1114, 601], "text": "into"}]}, {"boundingBox": [154, 607, 1155, 604, 1156, 635, 155, 637], "text": "the pharmaceutical business, under the clear-cut leadership of the CEO.", "words": [{"boundingBox": [155, 609, 194, 609, 195, 637, 155, 637], "text": "the"}, {"boundingBox": [216, 609, 403, 608, 403, 637, 216, 637], "text": "pharmaceutical"}, {"boundingBox": [417, 608, 539, 608, 540, 637, 418, 637], "text": "business,"}, {"boundingBox": [553, 608, 629, 607, 630, 637, 555, 637], "text": "under"}, {"boundingBox": [647, 607, 688, 607, 690, 637, 648, 637], "text": "the"}, {"boundingBox": [710, 607, 821, 607, 823, 636, 711, 636], "text": "clear-cut"}, {"boundingBox": [835, 607, 959, 606, 961, 636, 837, 636], "text": "leadership"}, {"boundingBox": [983, 606, 1017, 606, 1019, 636, 985, 636], "text": "of"}, {"boundingBox": [1031, 606, 1072, 606, 1075, 635, 1033, 636], "text": "the"}, {"boundingBox": [1094, 606, 1153, 605, 1156, 635, 1096, 635], "text": "CEO."}]}, {"boundingBox": [154, 642, 1154, 641, 1155, 670, 155, 671], "text": "Pharmaceutical Development Division is a core organization of Takeda Pharmaceutical", "words": [{"boundingBox": [155, 642, 334, 644, 334, 671, 155, 669], "text": "Pharmaceutical"}, {"boundingBox": [340, 644, 494, 645, 494, 672, 340, 671], "text": "Development"}, {"boundingBox": [499, 645, 590, 645, 590, 672, 500, 672], "text": "Division"}, {"boundingBox": [595, 645, 620, 645, 620, 672, 596, 672], "text": "is"}, {"boundingBox": [625, 645, 643, 645, 643, 672, 626, 672], "text": "a"}, {"boundingBox": [648, 645, 700, 645, 700, 672, 649, 672], "text": "core"}, {"boundingBox": [705, 645, 849, 645, 849, 672, 706, 672], "text": "organization"}, {"boundingBox": [856, 645, 883, 644, 883, 671, 857, 672], "text": "of"}, {"boundingBox": [888, 644, 975, 644, 976, 671, 888, 671], "text": "Takeda"}, {"boundingBox": [980, 644, 1154, 642, 1155, 669, 981, 671], "text": "Pharmaceutical"}]}, {"boundingBox": [155, 675, 1162, 673, 1162, 706, 156, 708], "text": "Company, enhancing the pipeline products, which is the decisive factor for TAKEDA", "words": [{"boundingBox": [156, 677, 276, 678, 277, 706, 156, 705], "text": "Company,"}, {"boundingBox": [282, 678, 406, 679, 406, 707, 282, 706], "text": "enhancing"}, {"boundingBox": [412, 679, 452, 679, 452, 707, 412, 707], "text": "the"}, {"boundingBox": [457, 679, 554, 679, 554, 707, 458, 707], "text": "pipeline"}, {"boundingBox": [559, 679, 671, 679, 671, 707, 560, 707], "text": "products,"}, {"boundingBox": [676, 679, 747, 679, 748, 707, 677, 707], "text": "which"}, {"boundingBox": [753, 679, 779, 678, 779, 707, 753, 707], "text": "is"}, {"boundingBox": [784, 678, 826, 678, 826, 707, 784, 707], "text": "the"}, {"boundingBox": [837, 678, 932, 677, 932, 706, 837, 707], "text": "decisive"}, {"boundingBox": [939, 677, 1009, 676, 1009, 705, 940, 706], "text": "factor"}, {"boundingBox": [1014, 676, 1052, 675, 1053, 705, 1015, 705], "text": "for"}, {"boundingBox": [1058, 675, 1160, 673, 1161, 704, 1058, 705], "text": "TAKEDA"}]}, {"boundingBox": [150, 709, 1162, 708, 1162, 739, 151, 741], "text": "business. However, in the present condition, since the launch of Actos in 1999 there", "words": [{"boundingBox": [153, 711, 266, 712, 265, 740, 153, 740], "text": "business."}, {"boundingBox": [271, 712, 384, 712, 384, 741, 271, 740], "text": "However,"}, {"boundingBox": [390, 712, 417, 712, 416, 741, 390, 741], "text": "in"}, {"boundingBox": [422, 712, 461, 713, 460, 741, 422, 741], "text": "the"}, {"boundingBox": [466, 713, 562, 713, 562, 741, 466, 741], "text": "present"}, {"boundingBox": [567, 713, 682, 712, 682, 741, 567, 741], "text": "condition,"}, {"boundingBox": [688, 712, 753, 712, 753, 741, 688, 741], "text": "since"}, {"boundingBox": [758, 712, 797, 712, 797, 741, 758, 741], "text": "the"}, {"boundingBox": [802, 712, 884, 711, 884, 740, 802, 741], "text": "launch"}, {"boundingBox": [892, 711, 919, 711, 919, 740, 892, 740], "text": "of"}, {"boundingBox": [925, 711, 991, 710, 991, 740, 925, 740], "text": "Actos"}, {"boundingBox": [997, 710, 1024, 710, 1024, 740, 997, 740], "text": "in"}, {"boundingBox": [1033, 710, 1093, 709, 1093, 740, 1033, 740], "text": "1999"}, {"boundingBox": [1098, 709, 1161, 708, 1161, 739, 1098, 740], "text": "there"}]}, {"boundingBox": [153, 744, 1156, 743, 1156, 774, 154, 776], "text": "are no new products launched. While this situation is critical, the Pharmaceutical", "words": [{"boundingBox": [156, 747, 196, 747, 196, 775, 156, 775], "text": "are"}, {"boundingBox": [204, 747, 240, 747, 240, 774, 204, 774], "text": "no"}, {"boundingBox": [250, 747, 295, 746, 295, 774, 249, 774], "text": "new"}, {"boundingBox": [310, 746, 416, 746, 416, 773, 310, 774], "text": "products"}, {"boundingBox": [424, 746, 547, 745, 546, 773, 423, 773], "text": "launched."}, {"boundingBox": [552, 745, 625, 745, 625, 773, 552, 773], "text": "While"}, {"boundingBox": [633, 745, 680, 745, 680, 773, 632, 773], "text": "this"}, {"boundingBox": [690, 745, 789, 745, 788, 773, 689, 773], "text": "situation"}, {"boundingBox": [800, 745, 825, 744, 824, 773, 799, 773], "text": "is"}, {"boundingBox": [834, 744, 924, 744, 923, 774, 834, 773], "text": "critical,"}, {"boundingBox": [930, 744, 970, 744, 969, 774, 929, 774], "text": "the"}, {"boundingBox": [979, 744, 1155, 743, 1154, 776, 978, 774], "text": "Pharmaceutical"}]}, {"boundingBox": [148, 776, 1163, 775, 1164, 807, 149, 807], "text": "Development Division is thought to be conservative and lack of challenging spirit. He", "words": [{"boundingBox": [153, 779, 309, 780, 310, 806, 154, 806], "text": "Development"}, {"boundingBox": [315, 780, 408, 780, 409, 806, 316, 806], "text": "Division"}, {"boundingBox": [414, 780, 439, 780, 440, 806, 415, 806], "text": "is"}, {"boundingBox": [444, 780, 536, 780, 537, 806, 445, 806], "text": "thought"}, {"boundingBox": [541, 780, 566, 780, 568, 806, 542, 806], "text": "to"}, {"boundingBox": [572, 780, 606, 780, 607, 806, 573, 806], "text": "be"}, {"boundingBox": [611, 780, 761, 779, 762, 807, 613, 806], "text": "conservative"}, {"boundingBox": [768, 779, 813, 779, 814, 807, 769, 807], "text": "and"}, {"boundingBox": [818, 779, 872, 779, 874, 807, 820, 807], "text": "lack"}, {"boundingBox": [878, 779, 905, 779, 906, 807, 879, 807], "text": "of"}, {"boundingBox": [910, 778, 1045, 777, 1046, 807, 911, 807], "text": "challenging"}, {"boundingBox": [1052, 777, 1119, 776, 1120, 807, 1054, 807], "text": "spirit."}, {"boundingBox": [1124, 776, 1162, 776, 1163, 807, 1126, 807], "text": "He"}]}, {"boundingBox": [147, 811, 1170, 813, 1169, 843, 146, 842], "text": "stated that his mission is to improve this conservative atmosphere and grow", "words": [{"boundingBox": [154, 813, 229, 814, 230, 841, 156, 840], "text": "stated"}, {"boundingBox": [243, 814, 296, 814, 298, 842, 245, 841], "text": "that"}, {"boundingBox": [305, 814, 346, 814, 348, 842, 307, 842], "text": "his"}, {"boundingBox": [358, 814, 449, 815, 451, 843, 360, 842], "text": "mission"}, {"boundingBox": [467, 815, 491, 815, 493, 843, 468, 843], "text": "is"}, {"boundingBox": [506, 815, 532, 815, 534, 843, 507, 843], "text": "to"}, {"boundingBox": [546, 815, 642, 815, 644, 843, 548, 843], "text": "improve"}, {"boundingBox": [658, 815, 705, 815, 706, 843, 660, 843], "text": "this"}, {"boundingBox": [720, 815, 870, 815, 871, 843, 722, 843], "text": "conservative"}, {"boundingBox": [886, 815, 1024, 814, 1026, 843, 887, 843], "text": "atmosphere"}, {"boundingBox": [1040, 814, 1088, 814, 1090, 843, 1042, 843], "text": "and"}, {"boundingBox": [1102, 813, 1157, 813, 1159, 842, 1104, 843], "text": "grow"}]}, {"boundingBox": [150, 847, 1090, 847, 1090, 877, 151, 878], "text": "challenging spirit to develop and launch the new products earlier than scheduled.", "words": [{"boundingBox": [155, 849, 288, 849, 288, 877, 155, 876], "text": "challenging"}, {"boundingBox": [293, 849, 349, 850, 348, 877, 293, 877], "text": "spirit"}, {"boundingBox": [354, 850, 381, 850, 381, 878, 354, 877], "text": "to"}, {"boundingBox": [388, 850, 478, 850, 477, 878, 388, 878], "text": "develop"}, {"boundingBox": [483, 850, 526, 850, 526, 878, 483, 878], "text": "and"}, {"boundingBox": [531, 850, 610, 850, 610, 878, 531, 878], "text": "launch"}, {"boundingBox": [616, 850, 653, 850, 653, 878, 615, 878], "text": "the"}, {"boundingBox": [659, 850, 705, 850, 705, 878, 658, 878], "text": "new"}, {"boundingBox": [712, 850, 814, 849, 814, 878, 712, 878], "text": "products"}, {"boundingBox": [820, 849, 895, 849, 895, 878, 820, 878], "text": "earlier"}, {"boundingBox": [900, 849, 954, 848, 954, 877, 900, 878], "text": "than"}, {"boundingBox": [960, 848, 1090, 847, 1090, 876, 960, 877], "text": "scheduled."}]}, {"boundingBox": [1228, 878, 1421, 878, 1420, 903, 1227, 902], "text": "Formatted: Not Hidden", "words": [{"boundingBox": [1233, 878, 1332, 880, 1331, 902, 1233, 903], "text": "Formatted:"}, {"boundingBox": [1337, 881, 1363, 881, 1363, 902, 1336, 902], "text": "Not"}, {"boundingBox": [1368, 881, 1421, 880, 1421, 903, 1368, 902], "text": "Hidden"}]}, {"boundingBox": [147, 949, 444, 949, 444, 978, 148, 979], "text": "3. MPDRAP-I (Diabetes)", "words": [{"boundingBox": [153, 950, 176, 950, 178, 979, 155, 979], "text": "3."}, {"boundingBox": [182, 950, 309, 950, 310, 979, 183, 979], "text": "MPDRAP-I"}, {"boundingBox": [315, 950, 443, 949, 444, 978, 315, 979], "text": "(Diabetes)"}]}, {"boundingBox": [153, 1018, 286, 1019, 286, 1047, 152, 1046], "text": "1) AD-4833", "words": [{"boundingBox": [155, 1020, 179, 1019, 180, 1047, 157, 1048], "text": "1)"}, {"boundingBox": [184, 1019, 286, 1019, 286, 1047, 186, 1047], "text": "AD-4833"}]}, {"boundingBox": [150, 1088, 497, 1088, 496, 1118, 149, 1117], "text": "Update of US status by TPNA", "words": [{"boundingBox": [154, 1088, 239, 1091, 240, 1118, 155, 1117], "text": "Update"}, {"boundingBox": [245, 1091, 269, 1091, 270, 1118, 246, 1118], "text": "of"}, {"boundingBox": [275, 1091, 311, 1091, 312, 1118, 276, 1118], "text": "US"}, {"boundingBox": [317, 1091, 385, 1091, 385, 1118, 317, 1118], "text": "status"}, {"boundingBox": [390, 1091, 423, 1091, 423, 1118, 391, 1118], "text": "by"}, {"boundingBox": [428, 1090, 496, 1089, 497, 1117, 429, 1118], "text": "TPNA"}]}, {"boundingBox": [193, 1121, 664, 1121, 664, 1150, 194, 1151], "text": "Bladder tumor observed in NN622 study", "words": [{"boundingBox": [203, 1123, 292, 1124, 291, 1150, 201, 1149], "text": "Bladder"}, {"boundingBox": [297, 1124, 366, 1124, 365, 1151, 296, 1150], "text": "tumor"}, {"boundingBox": [371, 1124, 478, 1124, 477, 1152, 370, 1151], "text": "observed"}, {"boundingBox": [483, 1124, 506, 1124, 506, 1152, 483, 1152], "text": "in"}, {"boundingBox": [511, 1123, 595, 1122, 595, 1151, 511, 1152], "text": "NN622"}, {"boundingBox": [600, 1122, 663, 1121, 664, 1151, 601, 1151], "text": "study"}]}, {"boundingBox": [149, 1155, 1163, 1156, 1162, 1187, 148, 1186], "text": "As for the bladder issues, an expected response from FDA is in early October and", "words": [{"boundingBox": [153, 1158, 189, 1158, 190, 1185, 154, 1185], "text": "As"}, {"boundingBox": [195, 1158, 231, 1158, 232, 1186, 196, 1185], "text": "for"}, {"boundingBox": [237, 1158, 277, 1158, 278, 1186, 238, 1186], "text": "the"}, {"boundingBox": [284, 1158, 377, 1158, 378, 1186, 285, 1186], "text": "bladder"}, {"boundingBox": [383, 1158, 470, 1158, 471, 1186, 383, 1186], "text": "issues,"}, {"boundingBox": [476, 1158, 509, 1158, 509, 1186, 476, 1186], "text": "an"}, {"boundingBox": [516, 1158, 625, 1158, 625, 1187, 516, 1186], "text": "expected"}, {"boundingBox": [631, 1158, 744, 1158, 744, 1187, 631, 1187], "text": "response"}, {"boundingBox": [751, 1158, 799, 1157, 799, 1187, 751, 1187], "text": "from"}, {"boundingBox": [813, 1157, 866, 1157, 866, 1187, 813, 1187], "text": "FDA"}, {"boundingBox": [877, 1157, 901, 1157, 901, 1187, 877, 1187], "text": "is"}, {"boundingBox": [906, 1157, 932, 1157, 931, 1187, 906, 1187], "text": "in"}, {"boundingBox": [941, 1157, 1003, 1157, 1003, 1187, 941, 1187], "text": "early"}, {"boundingBox": [1010, 1157, 1111, 1156, 1110, 1187, 1010, 1187], "text": "October"}, {"boundingBox": [1116, 1156, 1162, 1156, 1161, 1187, 1115, 1187], "text": "and"}]}, {"boundingBox": [148, 1193, 1162, 1190, 1163, 1219, 149, 1222], "text": "pediatric study (Actos 508) is temporarily on hold, however, this is not an official hold.", "words": [{"boundingBox": [153, 1194, 256, 1194, 257, 1221, 153, 1221], "text": "pediatric"}, {"boundingBox": [262, 1194, 326, 1194, 327, 1221, 262, 1221], "text": "study"}, {"boundingBox": [332, 1194, 409, 1194, 409, 1221, 332, 1221], "text": "(Actos"}, {"boundingBox": [414, 1194, 466, 1194, 467, 1221, 415, 1221], "text": "508)"}, {"boundingBox": [471, 1193, 495, 1193, 495, 1221, 472, 1221], "text": "is"}, {"boundingBox": [500, 1193, 634, 1193, 635, 1221, 501, 1221], "text": "temporarily"}, {"boundingBox": [640, 1193, 670, 1193, 671, 1221, 641, 1221], "text": "on"}, {"boundingBox": [675, 1193, 734, 1193, 736, 1221, 677, 1221], "text": "hold,"}, {"boundingBox": [740, 1193, 851, 1192, 852, 1221, 741, 1221], "text": "however,"}, {"boundingBox": [856, 1192, 899, 1192, 901, 1221, 858, 1221], "text": "this"}, {"boundingBox": [905, 1192, 928, 1192, 929, 1221, 906, 1221], "text": "is"}, {"boundingBox": [933, 1192, 974, 1192, 976, 1221, 935, 1221], "text": "not"}, {"boundingBox": [980, 1192, 1010, 1192, 1012, 1220, 981, 1221], "text": "an"}, {"boundingBox": [1017, 1192, 1094, 1191, 1096, 1220, 1019, 1220], "text": "official"}, {"boundingBox": [1100, 1191, 1161, 1191, 1162, 1220, 1102, 1220], "text": "hold."}]}, {"boundingBox": [152, 1226, 1165, 1226, 1165, 1256, 153, 1257], "text": "In the recent teleconference discussing non-clinical issues, the experts could not", "words": [{"boundingBox": [153, 1228, 180, 1228, 180, 1257, 153, 1257], "text": "In"}, {"boundingBox": [189, 1228, 233, 1228, 233, 1257, 189, 1257], "text": "the"}, {"boundingBox": [241, 1228, 324, 1229, 323, 1257, 241, 1257], "text": "recent"}, {"boundingBox": [329, 1229, 506, 1230, 505, 1258, 329, 1257], "text": "teleconference"}, {"boundingBox": [519, 1230, 642, 1230, 641, 1258, 519, 1258], "text": "discussing"}, {"boundingBox": [652, 1230, 792, 1229, 791, 1258, 651, 1258], "text": "non-clinical"}, {"boundingBox": [797, 1229, 888, 1229, 887, 1258, 797, 1258], "text": "issues,"}, {"boundingBox": [893, 1229, 935, 1228, 935, 1257, 892, 1257], "text": "the"}, {"boundingBox": [947, 1228, 1037, 1228, 1036, 1257, 946, 1257], "text": "experts"}, {"boundingBox": [1047, 1227, 1116, 1227, 1115, 1257, 1046, 1257], "text": "could"}, {"boundingBox": [1123, 1226, 1166, 1226, 1164, 1257, 1122, 1257], "text": "not"}]}, {"boundingBox": [152, 1261, 1161, 1260, 1162, 1291, 153, 1293], "text": "identify any rational hypothesis that dual PPAR agonists may be linked to bladder", "words": [{"boundingBox": [154, 1263, 244, 1262, 243, 1292, 153, 1292], "text": "identify"}, {"boundingBox": [252, 1262, 298, 1262, 297, 1292, 251, 1292], "text": "any"}, {"boundingBox": [303, 1262, 397, 1262, 396, 1293, 303, 1293], "text": "rational"}, {"boundingBox": [403, 1262, 535, 1262, 534, 1293, 402, 1293], "text": "hypothesis"}, {"boundingBox": [541, 1262, 594, 1262, 594, 1293, 540, 1293], "text": "that"}, {"boundingBox": [602, 1262, 654, 1261, 653, 1293, 601, 1293], "text": "dual"}, {"boundingBox": [659, 1261, 728, 1261, 728, 1293, 659, 1293], "text": "PPAR"}, {"boundingBox": [744, 1261, 845, 1261, 845, 1292, 743, 1293], "text": "agonists"}, {"boundingBox": [851, 1261, 906, 1261, 906, 1292, 851, 1292], "text": "may"}, {"boundingBox": [912, 1261, 948, 1261, 948, 1292, 912, 1292], "text": "be"}, {"boundingBox": [954, 1261, 1031, 1261, 1031, 1291, 954, 1292], "text": "linked"}, {"boundingBox": [1037, 1261, 1063, 1261, 1063, 1291, 1037, 1291], "text": "to"}, {"boundingBox": [1069, 1261, 1161, 1261, 1161, 1290, 1069, 1291], "text": "bladder"}]}, {"boundingBox": [154, 1295, 1159, 1293, 1160, 1324, 155, 1326], "text": "tumogenesis. A clinical expert meeting is scheduled for October 1 and 2 to discuss how", "words": [{"boundingBox": [156, 1297, 309, 1296, 308, 1326, 155, 1326], "text": "tumogenesis."}, {"boundingBox": [315, 1296, 334, 1296, 332, 1326, 314, 1326], "text": "A"}, {"boundingBox": [339, 1296, 419, 1296, 418, 1326, 338, 1326], "text": "clinical"}, {"boundingBox": [425, 1296, 498, 1296, 497, 1326, 424, 1326], "text": "expert"}, {"boundingBox": [504, 1296, 595, 1295, 594, 1326, 503, 1326], "text": "meeting"}, {"boundingBox": [601, 1295, 625, 1295, 624, 1326, 600, 1326], "text": "is"}, {"boundingBox": [631, 1295, 750, 1295, 749, 1326, 630, 1326], "text": "scheduled"}, {"boundingBox": [756, 1295, 787, 1295, 787, 1326, 755, 1326], "text": "for"}, {"boundingBox": [793, 1295, 890, 1295, 889, 1325, 792, 1326], "text": "October"}, {"boundingBox": [896, 1294, 911, 1294, 910, 1325, 895, 1325], "text": "1"}, {"boundingBox": [916, 1294, 961, 1294, 961, 1325, 916, 1325], "text": "and"}, {"boundingBox": [967, 1294, 982, 1294, 981, 1325, 966, 1325], "text": "2"}, {"boundingBox": [987, 1294, 1015, 1294, 1015, 1325, 987, 1325], "text": "to"}, {"boundingBox": [1021, 1294, 1103, 1294, 1103, 1324, 1020, 1325], "text": "discuss"}, {"boundingBox": [1109, 1294, 1157, 1294, 1157, 1324, 1108, 1324], "text": "how"}]}, {"boundingBox": [154, 1329, 1154, 1327, 1155, 1357, 155, 1359], "text": "to screen/monitor bladder tumors in long-term clinical trials, since FDA may force TPNA", "words": [{"boundingBox": [155, 1330, 176, 1330, 177, 1359, 156, 1359], "text": "to"}, {"boundingBox": [182, 1330, 352, 1330, 352, 1359, 183, 1359], "text": "screen/monitor"}, {"boundingBox": [357, 1330, 447, 1330, 448, 1359, 358, 1359], "text": "bladder"}, {"boundingBox": [453, 1330, 531, 1330, 532, 1359, 454, 1359], "text": "tumors"}, {"boundingBox": [537, 1330, 560, 1330, 561, 1359, 538, 1359], "text": "in"}, {"boundingBox": [565, 1330, 674, 1330, 675, 1359, 566, 1359], "text": "long-term"}, {"boundingBox": [684, 1330, 764, 1330, 765, 1359, 685, 1359], "text": "clinical"}, {"boundingBox": [770, 1330, 834, 1329, 835, 1359, 771, 1359], "text": "trials,"}, {"boundingBox": [840, 1329, 903, 1329, 904, 1358, 841, 1359], "text": "since"}, {"boundingBox": [909, 1329, 962, 1329, 963, 1358, 910, 1358], "text": "FDA"}, {"boundingBox": [968, 1329, 1018, 1328, 1019, 1358, 969, 1358], "text": "may"}, {"boundingBox": [1023, 1328, 1084, 1328, 1086, 1357, 1024, 1358], "text": "force"}, {"boundingBox": [1090, 1328, 1153, 1328, 1154, 1357, 1091, 1357], "text": "TPNA"}]}, {"boundingBox": [154, 1363, 1163, 1364, 1162, 1393, 153, 1392], "text": "to do it. Label changes may be requested by FDA and it is very difficult to assess the", "words": [{"boundingBox": [154, 1364, 179, 1364, 180, 1392, 154, 1392], "text": "to"}, {"boundingBox": [190, 1364, 216, 1364, 216, 1392, 191, 1392], "text": "do"}, {"boundingBox": [221, 1364, 247, 1364, 248, 1392, 222, 1392], "text": "it."}, {"boundingBox": [252, 1364, 320, 1365, 321, 1393, 253, 1392], "text": "Label"}, {"boundingBox": [325, 1365, 425, 1365, 426, 1393, 326, 1393], "text": "changes"}, {"boundingBox": [431, 1365, 482, 1365, 483, 1393, 432, 1393], "text": "may"}, {"boundingBox": [487, 1365, 520, 1365, 521, 1393, 489, 1393], "text": "be"}, {"boundingBox": [526, 1365, 644, 1365, 646, 1394, 527, 1394], "text": "requested"}, {"boundingBox": [650, 1365, 683, 1365, 684, 1394, 651, 1394], "text": "by"}, {"boundingBox": [688, 1365, 741, 1365, 742, 1394, 689, 1394], "text": "FDA"}, {"boundingBox": [748, 1365, 794, 1365, 795, 1394, 750, 1394], "text": "and"}, {"boundingBox": [799, 1365, 816, 1365, 817, 1394, 801, 1394], "text": "it"}, {"boundingBox": [821, 1365, 845, 1365, 847, 1393, 823, 1394], "text": "is"}, {"boundingBox": [850, 1365, 905, 1365, 907, 1393, 852, 1393], "text": "very"}, {"boundingBox": [912, 1365, 995, 1364, 996, 1393, 914, 1393], "text": "difficult"}, {"boundingBox": [1000, 1364, 1026, 1364, 1027, 1393, 1002, 1393], "text": "to"}, {"boundingBox": [1031, 1364, 1115, 1364, 1117, 1392, 1033, 1393], "text": "assess"}, {"boundingBox": [1120, 1364, 1161, 1364, 1163, 1392, 1122, 1392], "text": "the"}]}, {"boundingBox": [151, 1399, 1154, 1398, 1155, 1428, 152, 1429], "text": "marketing impact of such label change at this moment. It was suggested to prepare", "words": [{"boundingBox": [153, 1400, 270, 1400, 271, 1429, 154, 1428], "text": "marketing"}, {"boundingBox": [276, 1401, 360, 1401, 361, 1429, 277, 1429], "text": "impact"}, {"boundingBox": [366, 1401, 391, 1401, 392, 1429, 367, 1429], "text": "of"}, {"boundingBox": [397, 1401, 455, 1401, 456, 1429, 398, 1429], "text": "such"}, {"boundingBox": [461, 1401, 525, 1401, 526, 1429, 462, 1429], "text": "label"}, {"boundingBox": [530, 1401, 620, 1401, 621, 1429, 531, 1429], "text": "change"}, {"boundingBox": [627, 1401, 653, 1401, 654, 1429, 628, 1429], "text": "at"}, {"boundingBox": [658, 1401, 704, 1401, 705, 1430, 659, 1429], "text": "this"}, {"boundingBox": [709, 1401, 814, 1400, 815, 1429, 711, 1430], "text": "moment."}, {"boundingBox": [819, 1400, 841, 1400, 842, 1429, 820, 1429], "text": "It"}, {"boundingBox": [846, 1400, 900, 1400, 901, 1429, 848, 1429], "text": "was"}, {"boundingBox": [905, 1400, 1029, 1400, 1031, 1429, 906, 1429], "text": "suggested"}, {"boundingBox": [1035, 1400, 1062, 1400, 1064, 1429, 1036, 1429], "text": "to"}, {"boundingBox": [1068, 1400, 1154, 1399, 1155, 1428, 1069, 1429], "text": "prepare"}]}, {"boundingBox": [150, 1433, 791, 1435, 791, 1463, 149, 1461], "text": "non-clinical \"White paper\" to address the bladder issue.", "words": [{"boundingBox": [152, 1435, 285, 1435, 286, 1461, 153, 1461], "text": "non-clinical"}, {"boundingBox": [291, 1435, 369, 1435, 370, 1461, 292, 1461], "text": "\"White"}, {"boundingBox": [374, 1435, 453, 1435, 454, 1462, 375, 1461], "text": "paper\""}, {"boundingBox": [458, 1435, 484, 1435, 485, 1462, 459, 1462], "text": "to"}, {"boundingBox": [489, 1435, 581, 1435, 582, 1462, 490, 1462], "text": "address"}, {"boundingBox": [586, 1435, 624, 1435, 625, 1462, 587, 1462], "text": "the"}, {"boundingBox": [629, 1435, 716, 1435, 717, 1463, 630, 1462], "text": "bladder"}, {"boundingBox": [721, 1435, 789, 1436, 791, 1463, 722, 1463], "text": "issue."}]}, {"boundingBox": [190, 1499, 667, 1502, 666, 1530, 189, 1528], "text": "US commitment study of 30mg vs. 45mg", "words": [{"boundingBox": [204, 1500, 239, 1501, 237, 1529, 201, 1529], "text": "US"}, {"boundingBox": [245, 1501, 388, 1502, 386, 1530, 242, 1529], "text": "commitment"}, {"boundingBox": [394, 1502, 456, 1502, 454, 1530, 392, 1530], "text": "study"}, {"boundingBox": [461, 1503, 487, 1503, 486, 1530, 459, 1530], "text": "of"}, {"boundingBox": [493, 1503, 556, 1503, 555, 1530, 491, 1530], "text": "30mg"}, {"boundingBox": [562, 1503, 597, 1503, 596, 1530, 560, 1530], "text": "vs."}, {"boundingBox": [603, 1503, 667, 1503, 665, 1530, 602, 1530], "text": "45mg"}]}, {"boundingBox": [151, 1535, 1160, 1535, 1160, 1563, 152, 1564], "text": "An SNDA will be submitted in this autumn, where studies 341, 342, 343 and 513 are", "words": [{"boundingBox": [154, 1537, 188, 1537, 189, 1564, 155, 1564], "text": "An"}, {"boundingBox": [195, 1537, 263, 1537, 263, 1564, 196, 1564], "text": "SNDA"}, {"boundingBox": [271, 1537, 312, 1537, 313, 1564, 272, 1564], "text": "will"}, {"boundingBox": [318, 1537, 351, 1537, 352, 1564, 318, 1564], "text": "be"}, {"boundingBox": [359, 1537, 472, 1537, 473, 1564, 359, 1564], "text": "submitted"}, {"boundingBox": [478, 1537, 503, 1537, 503, 1564, 478, 1564], "text": "in"}, {"boundingBox": [510, 1537, 556, 1537, 556, 1564, 510, 1564], "text": "this"}, {"boundingBox": [563, 1537, 657, 1536, 657, 1564, 563, 1564], "text": "autumn,"}, {"boundingBox": [663, 1536, 737, 1536, 737, 1564, 663, 1564], "text": "where"}, {"boundingBox": [745, 1536, 832, 1536, 831, 1564, 744, 1564], "text": "studies"}, {"boundingBox": [839, 1536, 894, 1536, 893, 1564, 838, 1564], "text": "341,"}, {"boundingBox": [899, 1536, 954, 1536, 954, 1564, 899, 1564], "text": "342,"}, {"boundingBox": [960, 1536, 1006, 1536, 1005, 1564, 959, 1564], "text": "343"}, {"boundingBox": [1013, 1536, 1061, 1535, 1060, 1565, 1012, 1564], "text": "and"}, {"boundingBox": [1068, 1535, 1113, 1535, 1112, 1565, 1067, 1565], "text": "513"}, {"boundingBox": [1122, 1535, 1159, 1535, 1158, 1565, 1121, 1565], "text": "are"}]}, {"boundingBox": [152, 1569, 1163, 1571, 1162, 1600, 151, 1599], "text": "included. The objectives of the submission are for 1) a safety purpose, not for an", "words": [{"boundingBox": [153, 1570, 267, 1570, 267, 1599, 152, 1599], "text": "included."}, {"boundingBox": [273, 1570, 320, 1571, 320, 1600, 272, 1599], "text": "The"}, {"boundingBox": [330, 1571, 450, 1571, 450, 1600, 330, 1600], "text": "objectives"}, {"boundingBox": [458, 1571, 486, 1571, 486, 1600, 457, 1600], "text": "of"}, {"boundingBox": [492, 1571, 534, 1571, 534, 1600, 492, 1600], "text": "the"}, {"boundingBox": [542, 1571, 673, 1572, 673, 1600, 541, 1600], "text": "submission"}, {"boundingBox": [685, 1572, 725, 1572, 725, 1601, 685, 1600], "text": "are"}, {"boundingBox": [735, 1572, 775, 1572, 774, 1601, 734, 1601], "text": "for"}, {"boundingBox": [780, 1572, 809, 1572, 809, 1601, 780, 1601], "text": "1)"}, {"boundingBox": [815, 1572, 834, 1572, 834, 1600, 814, 1600], "text": "a"}, {"boundingBox": [841, 1572, 918, 1572, 918, 1600, 841, 1600], "text": "safety"}, {"boundingBox": [923, 1572, 1030, 1572, 1030, 1600, 923, 1600], "text": "purpose,"}, {"boundingBox": [1036, 1572, 1080, 1571, 1080, 1600, 1036, 1600], "text": "not"}, {"boundingBox": [1086, 1571, 1124, 1571, 1124, 1600, 1085, 1600], "text": "for"}, {"boundingBox": [1130, 1571, 1160, 1571, 1160, 1600, 1129, 1600], "text": "an"}]}, {"boundingBox": [153, 1605, 1166, 1603, 1166, 1634, 154, 1635], "text": "efficacy or new indication of 45mg, and 2) an update of oral contraceptive interaction", "words": [{"boundingBox": [155, 1607, 246, 1606, 246, 1634, 155, 1634], "text": "efficacy"}, {"boundingBox": [253, 1606, 278, 1606, 278, 1634, 253, 1634], "text": "or"}, {"boundingBox": [283, 1606, 329, 1606, 329, 1635, 283, 1635], "text": "new"}, {"boundingBox": [338, 1606, 454, 1605, 454, 1635, 338, 1635], "text": "indication"}, {"boundingBox": [461, 1605, 489, 1605, 489, 1635, 461, 1635], "text": "of"}, {"boundingBox": [495, 1605, 569, 1605, 569, 1635, 495, 1635], "text": "45mg,"}, {"boundingBox": [575, 1605, 621, 1605, 621, 1635, 575, 1635], "text": "and"}, {"boundingBox": [626, 1605, 654, 1605, 654, 1635, 626, 1635], "text": "2)"}, {"boundingBox": [660, 1605, 690, 1605, 690, 1635, 660, 1635], "text": "an"}, {"boundingBox": [697, 1605, 782, 1605, 782, 1635, 697, 1635], "text": "update"}, {"boundingBox": [788, 1605, 814, 1605, 814, 1635, 788, 1635], "text": "of"}, {"boundingBox": [820, 1605, 869, 1605, 869, 1635, 820, 1635], "text": "oral"}, {"boundingBox": [875, 1605, 1031, 1605, 1031, 1634, 875, 1635], "text": "contraceptive"}, {"boundingBox": [1036, 1605, 1161, 1604, 1161, 1633, 1036, 1634], "text": "interaction"}]}, {"boundingBox": [149, 1637, 374, 1638, 373, 1668, 148, 1667], "text": "results in the label.", "words": [{"boundingBox": [153, 1638, 230, 1638, 230, 1667, 153, 1668], "text": "results"}, {"boundingBox": [236, 1638, 258, 1638, 258, 1666, 236, 1667], "text": "in"}, {"boundingBox": [264, 1639, 302, 1639, 301, 1667, 264, 1666], "text": "the"}, {"boundingBox": [308, 1639, 373, 1640, 373, 1668, 307, 1667], "text": "label."}]}, {"boundingBox": [199, 1706, 985, 1708, 984, 1736, 198, 1735], "text": "Timelines and issues on Actos combination projects were presented.", "words": [{"boundingBox": [204, 1707, 314, 1708, 314, 1735, 204, 1734], "text": "Timelines"}, {"boundingBox": [319, 1708, 361, 1708, 361, 1735, 319, 1735], "text": "and"}, {"boundingBox": [366, 1708, 443, 1709, 443, 1735, 366, 1735], "text": "issues"}, {"boundingBox": [448, 1709, 478, 1709, 478, 1736, 448, 1735], "text": "on"}, {"boundingBox": [485, 1709, 550, 1709, 550, 1736, 485, 1736], "text": "Actos"}, {"boundingBox": [555, 1709, 694, 1710, 694, 1736, 555, 1736], "text": "combination"}, {"boundingBox": [700, 1710, 792, 1709, 792, 1736, 700, 1736], "text": "projects"}, {"boundingBox": [797, 1709, 855, 1709, 855, 1736, 797, 1736], "text": "were"}, {"boundingBox": [860, 1709, 984, 1708, 984, 1736, 860, 1736], "text": "presented."}]}, {"boundingBox": [152, 1741, 1162, 1740, 1163, 1770, 153, 1771], "text": "Actos-Metformin Convenience Pack is expected to file sNDA in March 2003 and to be", "words": [{"boundingBox": [153, 1742, 343, 1743, 344, 1771, 154, 1770], "text": "Actos-Metformin"}, {"boundingBox": [350, 1743, 504, 1744, 505, 1772, 351, 1771], "text": "Convenience"}, {"boundingBox": [509, 1744, 569, 1744, 570, 1772, 510, 1772], "text": "Pack"}, {"boundingBox": [575, 1744, 600, 1744, 602, 1772, 576, 1772], "text": "is"}, {"boundingBox": [606, 1744, 712, 1744, 713, 1772, 607, 1772], "text": "expected"}, {"boundingBox": [717, 1744, 743, 1744, 744, 1772, 718, 1772], "text": "to"}, {"boundingBox": [748, 1744, 786, 1744, 788, 1772, 749, 1772], "text": "file"}, {"boundingBox": [792, 1744, 859, 1743, 861, 1772, 793, 1772], "text": "sNDA"}, {"boundingBox": [865, 1743, 890, 1743, 892, 1771, 866, 1772], "text": "in"}, {"boundingBox": [896, 1743, 971, 1743, 972, 1771, 897, 1771], "text": "March"}, {"boundingBox": [978, 1743, 1040, 1742, 1041, 1771, 979, 1771], "text": "2003"}, {"boundingBox": [1046, 1742, 1089, 1741, 1091, 1770, 1047, 1771], "text": "and"}, {"boundingBox": [1095, 1741, 1122, 1741, 1124, 1770, 1096, 1770], "text": "to"}, {"boundingBox": [1128, 1741, 1161, 1741, 1162, 1770, 1129, 1770], "text": "be"}]}, {"boundingBox": [152, 1776, 1164, 1775, 1165, 1806, 153, 1807], "text": "approved in September 2003. TPNA believes stability data of 3 months are sufficient", "words": [{"boundingBox": [155, 1778, 264, 1777, 265, 1807, 156, 1807], "text": "approved"}, {"boundingBox": [270, 1777, 296, 1777, 297, 1807, 270, 1807], "text": "in"}, {"boundingBox": [303, 1777, 433, 1777, 434, 1807, 304, 1807], "text": "September"}, {"boundingBox": [439, 1777, 510, 1777, 511, 1807, 439, 1807], "text": "2003."}, {"boundingBox": [516, 1777, 583, 1776, 584, 1807, 516, 1807], "text": "TPNA"}, {"boundingBox": [591, 1776, 692, 1776, 693, 1807, 592, 1807], "text": "believes"}, {"boundingBox": [698, 1776, 792, 1776, 793, 1807, 699, 1807], "text": "stability"}, {"boundingBox": [799, 1776, 850, 1776, 851, 1807, 800, 1807], "text": "data"}, {"boundingBox": [856, 1776, 884, 1776, 885, 1807, 856, 1807], "text": "of"}, {"boundingBox": [890, 1776, 907, 1776, 907, 1807, 890, 1807], "text": "3"}, {"boundingBox": [912, 1776, 1002, 1776, 1003, 1807, 913, 1807], "text": "months"}, {"boundingBox": [1008, 1776, 1049, 1776, 1050, 1807, 1009, 1807], "text": "are"}, {"boundingBox": [1055, 1776, 1164, 1776, 1164, 1806, 1055, 1806], "text": "sufficient"}]}, {"boundingBox": [1140, 1848, 1160, 1845, 1159, 1871, 1139, 1874], "text": "2", "words": [{"boundingBox": [1143, 1847, 1159, 1844, 1163, 1869, 1146, 1872], "text": "2"}]}, {"boundingBox": [54, 2126, 530, 2126, 529, 2157, 53, 2156], "text": "Confidential - Subject to Protective Order", "words": [{"boundingBox": [56, 2126, 189, 2127, 189, 2157, 56, 2156], "text": "Confidential"}, {"boundingBox": [195, 2127, 213, 2127, 213, 2157, 195, 2157], "text": "-"}, {"boundingBox": [219, 2127, 303, 2127, 304, 2157, 219, 2157], "text": "Subject"}, {"boundingBox": [309, 2127, 333, 2127, 333, 2157, 309, 2157], "text": "to"}, {"boundingBox": [338, 2127, 454, 2127, 455, 2157, 339, 2157], "text": "Protective"}, {"boundingBox": [460, 2127, 529, 2127, 530, 2156, 461, 2157], "text": "Order"}]}, {"boundingBox": [1300, 2125, 1593, 2123, 1594, 2156, 1300, 2158], "text": "TAK-THOMCL-00012574", "words": [{"boundingBox": [1305, 2125, 1594, 2124, 1594, 2157, 1305, 2158], "text": "TAK-THOMCL-00012574"}]}, {"boundingBox": [377, 2193, 1312, 2192, 1312, 2230, 378, 2232], "text": "Source: https://www.indupto442coo02ts.ucsf.edu/docs/Imjf0226", "words": [{"boundingBox": [385, 2196, 500, 2196, 500, 2230, 385, 2229], "text": "Source:"}, {"boundingBox": [506, 2196, 1312, 2192, 1312, 2230, 506, 2230], "text": "https://www.indupto442coo02ts.ucsf.edu/docs/Imjf0226", "confidence": "Low"}]}, {"boundingBox": [1299, 2163, 1666, 2161, 1667, 2191, 1300, 2192], "text": "Produced in MDL on 09/14/12", "words": [{"boundingBox": [1301, 2164, 1419, 2164, 1418, 2190, 1300, 2193], "text": "Produced"}, {"boundingBox": [1424, 2164, 1449, 2164, 1449, 2190, 1424, 2190], "text": "in"}, {"boundingBox": [1455, 2164, 1514, 2164, 1514, 2189, 1455, 2190], "text": "MDL"}, {"boundingBox": [1519, 2164, 1552, 2163, 1552, 2190, 1519, 2189], "text": "on"}, {"boundingBox": [1557, 2163, 1666, 2162, 1666, 2192, 1557, 2190], "text": "09/14/12"}]}]}]}